Nifedipin Alternova (Nifedipine)

Nifedipine blocks L-type calcium channels in the smooth muscle of arteries. By preventing calcium entry, it reduces muscle contraction, leading to vasodilation. This lowers peripheral resistance, decreases blood pressure, and enhances coronary blood flow, which alleviates angina and improves circulation in Raynaud's phenomenon.

The appropriate dose of Nifedipin Alternova is determined by the prescribing clinician based on the patient’s specific condition, response, and other medical factors. Dosage regimens are individualized and should follow the prescriber’s instructions and local regulatory guidelines.

The safety of nifedipine in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nifedipine belongs to the dihydropyridine calcium‑channel blocker class, which primarily causes arterial vasodilation. Compared with beta‑blockers or ACE inhibitors, it has a more pronounced effect on peripheral vessels and may cause flushing or edema, but it is often combined with other agents for synergistic blood‑pressure control.

Store Nifedipin Alternova at room temperature, below 25 °C, in the original packaging. Keep the product away from moisture and direct sunlight to maintain its stability and potency throughout its shelf life.

Nifedipin Alternova is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include severe hypotension, myocardial infarction, and rare allergic reactions such as anaphylaxis. Patients should be monitored for signs of sudden blood‑pressure drops, chest pain, or any hypersensitivity symptoms and seek immediate medical attention if they occur.

Individuals with known hypersensitivity to nifedipine or any component of the formulation should avoid the product. Caution is also advised for patients with severe aortic stenosis, uncontrolled heart failure, or those taking contraindicated medications that may cause dangerous interactions.